Skip to main content
. 2020 Jun 14;12(6):e8611. doi: 10.7759/cureus.8611

Table 2. First-Line Chemotherapy Regimens.

ABVD: Adriamycin (doxorubicin), bleomycin, vinblastine, dacarbazine; CHOEP: cyclophosphamide, doxorubicin, etoposide, vincristine, prednisone; CODOX: cyclophosphamide, vincristine, doxorubicin; R-CHOP: rituximab, cyclophosphamide, doxorubicin, vincristine, prednisone; R-EPOCH: rituximab, etoposide phosphate, prednisone, vincristine sulfate (Oncovin), cyclophosphamide, and doxorubicin hydrochloride (hydroxydaunorubicin)

Chemotherapy regimens All Patients n (%) Indolent n (%) Aggressive n (%) P-value
R-CHOP 8 (40) 4 (40) 4 (40) 1
Rituximab 4 (20) 3 (30) 1 (10) 0.58
R-EPOCH 3 (15) 0 (0) 3 (30) 0.21
Rituximab/bendamustine 2 (10) 2 (20) 0 (0) 0.47
ABVD 1 (5) 1 (10) 0 (0) 1
CHOEP 1 (5) 0 (0) 1 (10) 1
CODOX 1 (5) 0 (0) 1 (10) 1